Psyched Wellness Attracts Major Investment

Jeffrey Stevens, CEO & Director of Psyched Wellness (CSE: PSYC) joins us in today’s episode of the Daily Dive. Jeff sits down with us to discuss the evolution of the stigma towards mushrooms, and the interest in psychedelics. We then transition to a discussion on Psyched Wellness, where we hear about the process of development of CALM, the firms latest product, as well as the recent binding agreement with Gotham Green and My Crew Doses Inc.

Psyched Wellness is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category.


Information for this briefing was found via Sedar and the companies mentioned. Canacom Group, the parent company of the Deep Dive, is currently long the equity of Psyched Wellness. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

Psyched Wellness Completes Extraction Protocol For First Mushroom Products

Psyched Wellness (CSE: PSYC) has completed a number of milestones with regards to getting its...

Thursday, December 10, 2020, 07:45:56 AM

Will There Be A New Currency Backed by Gold? — With David Watkinson of Emergent Metals

Joining us today on the Daily Dive for the first time is David Watkinson, CEO...

Tuesday, February 21, 2023, 01:30:00 PM

$4000 Gold, And We’re Just Getting Started! | Peter Grandich

In this interview, Peter Grandich provides an analysis of the current global economic landscape, exploring...

Tuesday, April 22, 2025, 01:38:00 PM

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley...
Saturday, April 26, 2025, 11:38:00 AM

Trans Canada Gold: Developing A Red Lake Lookalike In Ontario – The Daily Dive feat Tim Coupland

For our Sunday edition of The Daily Dive, we sit down to discuss gold exploration...

Monday, February 22, 2021, 01:30:00 PM